4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-009079
Director sold 15,470 shares at an average $347.45 ($5,375,126)
- Director acquired 15,470 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Daly James M Director | 2025-02-27 | Option exercise | +9,470 | $65.06 | $616,118 | 11,382 | D |
| Daly James M Director | 2025-02-27 | Option exercise | +6,000 | $111.06 | $666,360 | 17,382 | D |
| Daly James M Director | 2025-02-27 | Sale | −398 | $346.90 | $138,067 | 16,984 | D |
| Daly James M Director | 2025-02-27 | Sale | −14,302 | $347.39 | $4,968,372 | 2,682 | D |
| Daly James M Director | 2025-02-27 | Sale | −770 | $348.94 | $268,686 | 1,912 | D |
| Derivatives | |||||||
| Daly James M Director | 2025-02-27 | Option exercise · Stock Option (Right to Buy) | −9,470 | 0 | D | ||
| Daly James M Director | 2025-02-27 | Option exercise · Stock Option (Right to Buy) | −6,000 | 0 | D | ||
| Open-market sales · 15,470 sh · avg $347.45 · $5,375,126 | |||||||
Loading xslF345X05/wk-form4_1740778263.xml…